Nalu Medical

Nalu Medical is a Carlsbad, California-based neurotechnology company operating at the forefront of the neuromodulation space. The company has developed the Nalu Neurostimulation System, a groundbreaking implantable device designed to treat chronic back and limb pain. At the heart of their innovation is a micro-sized, rechargeable implantable pulse generator that represents a significant departure from the bulky, conventional devices that have long defined the spinal cord stimulation market. The system supports flexible programming options and remote care capabilities, allowing clinicians to adjust patient therapy without requiring in-person visits, a feature with meaningful implications for long-term patient outcomes and access to care.

Nalu Medical has demonstrated strong investor confidence, having raised $125 million in Series D funding, bringing its total capitalization to a level that positions the company as a serious commercial and clinical contender in the neuromodulation market. The company has progressed through regulatory and clinical milestones that have enabled it to bring its system to market and expand its footprint among pain management specialists and implanting physicians. Their focus on miniaturization combined with rechargeability addresses longstanding clinical complaints about device comfort, longevity, and patient compliance. This funding trajectory reflects growing industry and investor recognition of the unmet need Nalu is working to address within the chronic pain treatment landscape.

Nalu Medical represents an important evolution in how the neurotech industry approaches implantable therapy for chronic pain, a condition affecting hundreds of millions of people worldwide and generating significant healthcare costs. By delivering a device that is dramatically smaller than legacy systems without sacrificing therapeutic capability, the company challenges incumbents such as Medtronic, Abbott, and Boston Scientific to accelerate their own innovation cycles. Their integration of remote care functionality also signals a broader industry shift toward connected, patient-centric neuromodulation that aligns with the digitization of healthcare delivery. As the neuromodulation market continues to grow, Nalu Medical stands as a compelling example of how focused engineering and clinical strategy can redefine the standard of care in an established therapeutic category.